These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 1847697)
1. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth. Fallon MT; Benjamin WH; Schoeb TR; Briles DE Infect Immun; 1991 Mar; 59(3):852-6. PubMed ID: 1847697 [TBL] [Abstract][Full Text] [Related]
2. Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV). Fallon MT; Schoeb TR; Benjamin WH; Lindsey JR; Briles DE Microb Pathog; 1989 Feb; 6(2):81-91. PubMed ID: 2541308 [TBL] [Abstract][Full Text] [Related]
3. The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing. Benjamin WH; Hall P; Roberts SJ; Briles DE J Immunol; 1990 Apr; 144(8):3143-51. PubMed ID: 2182715 [TBL] [Abstract][Full Text] [Related]
4. The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice. Gulig PA; Doyle TJ Infect Immun; 1993 Feb; 61(2):504-11. PubMed ID: 8423080 [TBL] [Abstract][Full Text] [Related]
5. Analysis of host cells associated with the Spv-mediated increased intracellular growth rate of Salmonella typhimurium in mice. Gulig PA; Doyle TJ; Hughes JA; Matsui H Infect Immun; 1998 Jun; 66(6):2471-85. PubMed ID: 9596705 [TBL] [Abstract][Full Text] [Related]
6. Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse. Shea JE; Beuzon CR; Gleeson C; Mundy R; Holden DW Infect Immun; 1999 Jan; 67(1):213-9. PubMed ID: 9864218 [TBL] [Abstract][Full Text] [Related]
7. Immunity conferred by Aro- Salmonella live vaccines. Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952 [TBL] [Abstract][Full Text] [Related]
8. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Izhar M; DeSilva L; Joysey HS; Hormaeche CE Infect Immun; 1990 Jul; 58(7):2258-61. PubMed ID: 2194967 [TBL] [Abstract][Full Text] [Related]
9. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Mastroeni P; Villarreal-Ramos B; Hormaeche CE Microb Pathog; 1993 Jun; 14(6):473-80. PubMed ID: 8412619 [TBL] [Abstract][Full Text] [Related]
10. Role of sigma factor RpoS in initial stages of Salmonella typhimurium infection. Nickerson CA; Curtiss R Infect Immun; 1997 May; 65(5):1814-23. PubMed ID: 9125566 [TBL] [Abstract][Full Text] [Related]
11. Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha. Gulig PA; Doyle TJ; Clare-Salzler MJ; Maiese RL; Matsui H Infect Immun; 1997 Dec; 65(12):5191-7. PubMed ID: 9393815 [TBL] [Abstract][Full Text] [Related]
12. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Mastroeni P; Villarreal-Ramos B; Hormaeche CE Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824 [TBL] [Abstract][Full Text] [Related]
13. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959 [TBL] [Abstract][Full Text] [Related]
14. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts. Khanolkar A; Fulton RB; Epping LL; Pham NL; Tifrea D; Varga SM; Harty JT J Immunol; 2010 Jul; 185(2):1132-41. PubMed ID: 20554960 [TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Mastroeni P; Harrison JA; Chabalgoity JA; Hormaeche CE Infect Immun; 1996 Jan; 64(1):189-96. PubMed ID: 8557339 [TBL] [Abstract][Full Text] [Related]
16. Salmonella typhimurium strains carrying independent mutations display similar virulence phenotypes yet are controlled by distinct host defense mechanisms. Raupach B; Kurth N; Pfeffer K; Kaufmann SH J Immunol; 2003 Jun; 170(12):6133-40. PubMed ID: 12794143 [TBL] [Abstract][Full Text] [Related]
17. Differences in the carriage and the ability to utilize the serotype associated virulence plasmid in strains of Salmonella enterica serotype Typhimurium investigated by use of a self-transferable virulence plasmid, pOG669. Olsen JE; Brown DJ; Thomsen LE; Platt DJ; Chadfield MS Microb Pathog; 2004 Jun; 36(6):337-47. PubMed ID: 15120160 [TBL] [Abstract][Full Text] [Related]
18. Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Stocker BA; Hoiseth SK; Smith BP Dev Biol Stand; 1983; 53():47-54. PubMed ID: 6307785 [TBL] [Abstract][Full Text] [Related]
19. In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimurium. Kraft AS; Adler V; Hall P; Pettit GR; Benjamin WH; Briles DE Cancer Res; 1992 Apr; 52(8):2143-7. PubMed ID: 1559218 [TBL] [Abstract][Full Text] [Related]
20. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]